Phase I trial of adoptive immunotherapy with cytolytic T lymphocytes immunized against a tyrosinase epitope

J Clin Oncol. 2002 Jul 15;20(14):3176; author reply 3176-7. doi: 10.1200/JCO.2002.20.14.3176.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Asparagine / metabolism
  • Aspartic Acid / metabolism
  • Clinical Trials, Phase I as Topic
  • Codon
  • Deamination
  • Epitopes, T-Lymphocyte / immunology*
  • Humans
  • Immunotherapy, Adoptive / methods*
  • Melanoma / enzymology
  • Melanoma / immunology
  • Melanoma / therapy*
  • Monophenol Monooxygenase / genetics*
  • Monophenol Monooxygenase / immunology*
  • Neoplasm Proteins / genetics
  • Neoplasm Proteins / immunology
  • Neoplasm Proteins / metabolism*
  • Protein Processing, Post-Translational / genetics
  • Sequence Analysis, DNA
  • T-Lymphocytes / enzymology
  • T-Lymphocytes / immunology
  • T-Lymphocytes / metabolism*
  • T-Lymphocytes / transplantation*
  • Transplantation, Autologous

Substances

  • Codon
  • Epitopes, T-Lymphocyte
  • Neoplasm Proteins
  • Aspartic Acid
  • Asparagine
  • Monophenol Monooxygenase